Cornucopian Capital Management
Venture capitalMontclair · Pre-Seed–Series A
Investment thesis
Cornucopian Capital deploys long-term capital to build and back results-oriented, high-integrity companies working to make improved healthspan, enhanced performance, and extended longevity accessible to everyone. The firm frames its focus as 'Medicine 3.0,' supporting early-stage ventures that apply scientific knowledge and accessible technologies to deliver health products and services to consumers, patients, and healthcare providers. It emphasizes adding value through its capabilities, strategic partnerships, institutional networks, and collaborators.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 13 of 15 portfolio companiesBiotech ×8Deep Tech ×6AI & Machine Learning ×5Healthtech ×5Digital Health ×4FoodTech ×3Longevity ×3AgTech ×1
HQs:United States×9
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×52 founders×23 founders×14+ founders×1
Where their founders worked beforefrom 10 founders with career history
Institute for Protein Design, University of Washington ×2
Investments · 15 tracked
founders shown can be your intro pathBy year:2026 · 22022 · 22019 · 15 dated
Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications.
AI & Machine LearningBiotechDeep TechSeattle, US
George Ueda, Ph.D.(Chief Technology Officer, Co-Founder)James Lazarovits, Ph.D.(Chief Executive Officer, Co-Founder)James Lazarovits(Founder)inGeorge Ueda(Founder)in
Co-investorsMadrona Venture GroupY Combinator
Barnstorm Foundry is a venture studio focused on building and launching life sciences and biotech companies, drawing on advisors in talent acquisition, commercialization, IP, corporate law, and biosensor technology.
BiotechDeep TechHealthtech
Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor.
BiotechDeep TechFoodTechSeattle, US
Eric Steven Quick(Executive Officer, Director)Aryeh Ganz(Executive Officer, Director, Promoter)
BoardFrank Curzio(Director)
Co-investorsBaruch Future Ventures
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCRV (Charles River Ventures)Owl CapitalquadraScope Venture FundAxial VC+1 more
Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development.
AI & Machine LearningBiotechDeep Tech
Marty BurkeBartosz GrzybowskiMichael Foley(CEO)inJana Jensen(COO)in
Co-investorsKhosla VenturesSofinnova PartnersIllinois Ventures
Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists.
Digital HealthHealthtechMental Health
Sahil Choudhryin
Co-investors25MadisonCobalt VenturesNextView VenturesNVP CapitalRPS VenturesVamosVentures+3 more
Claymont, US
Elina Onitskansky(Executive Officer, Director, Promoter)in
BoardAryeh Ganz(Director)Matthew Klitus(Director)
Co-investorsCity LightLifeX VenturesPeakBridge VC
InsideTracker provides personalized health insights by analyzing biological markers and genetic data to deliver customized recommendations for nutrition, fitness, and lifestyle optimization for individuals seeking longevity and preventive wellness.
AI & Machine LearningBiotechConsumerDigital HealthHealthtechLongevityCambridge, US
Co-investorsPeakBridge VC
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms.
BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness
Chris Mirabile(Founder & CEO)in
Co-investorsFab Co-Creation Studio VenturesResolute VenturesKaedan CapitalMizMaa VenturesRemagine VenturesUNCOMMON DENOMINATOR
Nowadays is an AI-powered platform for corporate event planning that handles tasks from venue sourcing to budget management.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSSan Francisco, US
Anna Sun(CEO)inAmy Yan(COO)inAnthony Puterman(Cofounder)Justin Tidwell(Cofounder)in
Co-investorsThe E14 FundY CombinatorGaingelsSelva VenturesStray Dog CapitalTenacious Ventures+1 more
Persperion Diagnostics develops touch-based sweat sensing technology for diagnostic measurement.
Deep TechDigital HealthMedical Devices
Co-investors7G BioVenturesFoothill VenturesSamsung Next
PhenoTap develops KetoTap Core, a patent-pending BHB oxidase enzyme designed for reliable, affordable, real-time ketone measurement in blood test strips and continuous monitors.
BiotechDeep TechHealthtech
Giovanni Battistini(CEO & Co-Founder)inJanet Tamada(VP of Biosensing & Co-Founder)inJoe Wang(Chief Biosensing Scientist & Co-Founder)Ray Garcia(CTO)
Tastewise is an AI-powered consumer intelligence platform for food and beverage brands, turning consumer, menu, and social data into insights for product innovation, marketing, and sales.
AI & Machine LearningData & InfrastructureFoodTechNew York City, US
Co-investorsDisruptive AIPeakBridge VC
Zero Acre Farms produces cooking oils optimized for chefs and restaurants, using organic fera fruit oil as an alternative to seed oils with superior heat stability, cleaner taste, and healthier fat profiles.
AgTechFoodTechImpact & Social GoodSan Francisco, US
Jeff Nobbs(Founder & CEO)in
Co-investorsCollaborative FundDesigner FundFifty YearsHabitat PartnersHyperguapJuniper+8 more
Portfolio news
latest coverage across their companies
Zero Acre Farms · zeroacre.com · Aug 14, 2026
Ilant Health · fiercehealthcare.com · Jul 22, 2026
Nowadays · ycombinator.com · Jun 16, 2026
Tastewise · techfundingnews.com · Jun 12, 2025
Frequently asked questions
- How many investments has Cornucopian Capital Management made?
- Cornucopian Capital Management has 14 tracked investments, including 2 dated in the last 24 months.
- What stage does Cornucopian Capital Management invest at?
- Cornucopian Capital Management invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Cornucopian Capital Management focus on?
- Cornucopian Capital Management focuses on Biotech, Consumer, Digital Health, FoodTech, Healthtech, Longevity, Medical Devices, Wellness & Fitness.
- Where is Cornucopian Capital Management located?
- Cornucopian Capital Management is headquartered in Montclair, US.
- Who does Cornucopian Capital Management co-invest with?
- Cornucopian Capital Management most often shares deals with PeakBridge VC, Collaborative Fund, CRV (Charles River Ventures), among 35 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Exceptional Ventures is a London-based early-stage venture capital firm investing in high-impact startups that help people live healthier, happier, and longer lives while supporting a healthy planet.
Pave Health Ventures is an early-stage investor and company builder focused on health, backing founders from the ideation stage across products, technology, and tech-enabled services.
Able Partners is a New York-based early-stage venture firm backing consumer and health/wellness brands aimed at improving physical and mental wellbeing.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.